In patients with haemophilia (PwH), the ankle joint is most prone to recurrent bleeding episodes that set up a complex pathogenesis resulting in synovial hypertrophy, bone cysts, ankylosis and eventually end-stage arthritis. 1,2 This phenomenon, called haemophilic ankle arthropathy, is currently the most disabling comorbidity in PwH 3 and leads to functional limitations and pain during walking. 4 Several conservative treatment strategies have been proposed to manage these functional limitations and pain during walking, such as therapeutic footwear and foot orthoses. 4-6 Although conventional walking shoes are not specifically designed for therapeutic purposes, clinical experience dictates that patients often prefer walking